Andrew Spicer is the CEO of Algenuity and a Director of Spicer Consulting Limited. Andrew received a Ph.D. in molecular and cell biology in 1993 from University College London through his doctoral research at the Imperial Cancer Research Fund (now Cancer Research UK) Laboratories in Lincoln’s Inn Fields, London.
He went on to complete a postdoctoral research fellowship at the Mayo Clinic Scottsdale. He has published over 35 research articles in peer-reviewed journals, and is an acknowledged expert in gene characterisation, expression, manipulation and function in eukaryotes. His articles have collectively been cited over 3000 times since publication. Andrew joined Spicer Consulting to spearhead the development of the Algal Biotech Division in 2009. He is now an acting scientific advisor on several national and international high-profile algal biotechnology research projects, and a member of the management board of the UK's Phyconet Network in Industrial Biotechnology.
Michael Yates serves as Head of Business Development for Algenuity. Prior to working for Algenuity, Michael worked for a nonprofit organisation in Boston, USA, where he pioneered a social entrepreneurship project serving townships in South Africa. Michael is a graduate of MIT.
Jane Purton supports the company as the Operations Manager. She has worked in a number of roles for multinational companies, local government, large business enterprises and start-up ventures. Jane has a varied background in business administration, finance and product quality.
Michiel Matthijs serves as the Chief Scientific Officer of Algenuity. Michiel graduated from Ghent University with an M.Sc. in Biochemistry and Biology in 2009. His master's thesis was focused on the cell cycle similarities between the plant Arabidopsis thaliana and the human cell cycle. Immediately afterwards he started his Ph.D. under the joint promotership of Prof. Dr. Wim Vyverman and Prof. Dr. Alain Goossens.
He successfully defended his thesis entitled 'A first look at nitrogen starvation in the diatom Phaeodactylum tricornutum' in September 2014. Michiel joined the Algenuity team in June 2014, focusing on the commercial applications of brown algae within the synthetic phycology landscape.